, a bio/informatics shared resource is still "open for business" - Visit the CDS website

High one year mortality in adults with sickle cell disease and end-stage renal disease.

McClellan AC, Luthi JC, Lynch JR, Soucie JM, Kulkarni R, Guasch A, Huff ED, Gilbertson D, McClellan WM, DeBaun MR
Br J Haematol. 2012 159 (3): 360-7

PMID: 22967259 · PMCID: PMC4562224 · DOI:10.1111/bjh.12024

Adequate pre-dialysis care reduces mortality among end-stage renal disease (ESRD) patients. We tested the hypothesis that individuals with ESRD due to sickle cell disease (SCD-ESRD) receiving pre-ESRD care have lower mortality compared to individuals without pre-ESRD care. We examined the association between mortality and pre-ESRD care in incident SCD-ESRD patients who started haemodialysis between 1 June, 2005 and 31 May, 2009 using data provided by the Centers for Medicare and Medicaid Services (CMS). SCD-ESRD was reported for 410 (0·1%) of 442 017 patients. One year after starting dialysis, 108 (26·3%) patients with incident ESRD attributed to SCD died; the hazard ratio (HR) for mortality among patients with SCD-ESRD compared to those without SCD as the primary cause of renal failure was 2·80 (95% confidence interval [CI] 2·31-3·38). Patients with SCD-ESRD receiving pre-dialysis nephrology care had a lower death rate than those with SCD-ESRD who did not receive pre-dialysis nephrology care (HR = 0·67, 95% CI 0·45-0·99). The one-year mortality rate following an ESRD diagnosis was almost three times higher in individuals with SCD when compared to those without SCD but with ESRD and could be attenuated by pre-dialysis nephrology care.

© 2012 Blackwell Publishing Ltd.

MeSH Terms (10)

Aged Aged, 80 and over Anemia, Sickle Cell Female Humans Kidney Failure, Chronic Male Middle Aged Renal Dialysis Treatment Outcome

Connections (2)

This publication is referenced by other Labnodes entities: